product summary
Loading...
company name :
Bio-Rad
other brands :
Biogenesis, Serotec, AbD Serotec, Oxford Biotechnology
product type :
antibody
product name :
Mouse anti NF Kappa B Inhibitor Alpha
catalog :
VMA00150
quantity :
100 µl
price :
381 USD
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
clone name :
OTI1D4
reactivity :
human
application :
western blot, immunoprecipitation
more info or order :
Bio-Rad product webpage
image
image 1 :
Bio-Rad VMA00150 image 1
Western blot analysis of whole cell lysates probed with NF kappa B inhibitor alpha antibody followed by detection with HRP conjugated Goat anti Mouse IgG (1/10,000, STAR207P ) and visualized on the ChemiDoc™ MP with 67 second exposure. Arrow points to NF kappa B inhibitor alpha (molecular weight 35 kDa)
product information
Entity Type :
PrecisionAb Monoclonal
Entity Category :
Antibodies
ProductCode :
VMA00150
Description :
Mouse anti NF Kappa B Inhibitor Alpha
Specificity :
NF Kappa B Inhibitor Alpha
TargetSpecies :
Human
Host :
Mouse
Format :
Purified
Isotypes :
IgG1
Applications :
WB,IP
ApplicationTypes :
Western Blotting,Immunoprecipitation
Cross Reactivities :
Rat,Mouse
Clone :
OTI1D4
Quantity :
100 µl
Quantity Value :
100
Quantity Type :
ul
GO Accessions :
GO:0005886,GO:0002755,GO:0002756,GO:0006915,GO:0005829,GO:0005634,GO:0006916,GO:0007253,GO:0008063,GO:0008139,GO:0042802,GO:0010552,GO:0010745,GO:0010875,GO:0010888,GO:0031625,GO:0032088,GO:0032270,GO:0033256,GO:0034130,GO:0034134,GO:0034138,GO:0034142,GO:0044419,GO:0045087,GO:0048011,GO:0050852,GO:0051059,GO:0051092
GOTerms :
plasma membrane,MyD88-dependent toll-like receptor signaling pathway,MyD88-independent toll-like receptor signaling pathway,apoptosis,cytosol,nucleus,anti-apoptosis,cytoplasmic sequestering of NF-kappaB,Toll signaling pathway,nuclear localization sequence binding,identical protein binding,positive regulation of gene-specific transcription from RNA polymerase II promoter,negative regulation of macrophage derived foam cell differentiation,positive regulation of cholesterol efflux,negative regulation of lipid storage,ubiquitin protein ligase binding,negative regulation of NF-kappaB transcription factor activity,positive regulation of cellular protein metabolic process,I-kappaB/NF-kappaB complex,toll-like receptor 1 signaling pathway,toll-like receptor 2 signaling pathway,toll-like receptor 3 signaling pathway,toll-like receptor 4 signaling pathway,interspecies interaction between organisms,innate immune response,nerve growth factor receptor signaling pathway,T cell receptor signaling pathway,NF-kappaB binding,positive regulation of NF-kappaB transcription factor activity
Uniprot Accessions :
P25963
Gene :
NFKBIA
GeneID URL :
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=4792
Entity Formats :
Purified
UNSPSC :
41116161
Concentration :
IgG concentration 0.5 mg/ml.
Product Form :
Purified IgG - liquid
PriceGBP :
289
PriceEUR :
370
PriceUSD :
381 USD
PriceCHF :
402
PriceSEK :
4033
PriceNOK :
4053
PriceDKK :
2759
more info or order :
Bio-Rad product webpage
company information
Bio-Rad
Endeavour House, Langford Business Park
Langford Lane, Kidlington
OXON, OX5 1GE
antibody_sales_uk@bio-rad.com
https://www.bio-rad-antibodies.com
1 800 265 7376 (North America)
44 (0)1865 852 700 (Rest of World)
headquarters: UK
Bio-Rad is one of the world's leading antibody manufacturers, offering over 12,000 antibodies and related reagents for a focused range of research areas such as immunology, cancer, veterinary research and cell biology through its antibody experts formerly known as AbD Serotec.
The range includes apoptosis kits, autophagy reagents, CD markers, epitope tag antibodies, immunology antibodies, neuroscience antibodies, and veterinary reagents.
Bio-Rad has an ISO 9001 and ISO 13485 certified production facility in the United Kingdom as well as ISO 9001 certified facilities in Germany and the United States.
Our expertise extends to traditional and recombinant antibody generation and production services. Our custom generation service delivers antibodies in as little as 8 weeks with greater than 90% success. The in vitro technology enables selection of antibodies to challenging targets, long term consistent supply, and provision of the antibody sequence.
At Bio-Rad we are committed to your success when using our antibodies and we focus on providing the technology, products and all the supporting information you need to excel in your research.